Lilly Feels Statistical Pain, Withdraws Cymbalta sNDA
This article was originally published in The Pink Sheet Daily
Executive Summary
Firm will resubmit the application for chronic pain in 2009 along with a recently completed study using FDA’s preferred analysis for patient drop outs.